BioSyent Inc. (BIOYF)
OTCMKTS: BIOYF · Delayed Price · USD
7.31
+0.72 (10.94%)
Jul 22, 2024, 4:00 PM EDT - Market closed
BioSyent Revenue
BioSyent had revenue of 32.84M CAD in the twelve months ending March 31, 2024, with 19.99% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 7.73M with 19.30% year-over-year growth. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.
Revenue (ttm)
32.84M CAD
Revenue Growth
+19.99%
P/S Ratio
3.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
86.21M undefined
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
Dec 31, 2019 | 21.42M | -102.70K | -0.48% |
Dec 31, 2018 | 21.53M | 764.27K | 3.68% |
Dec 31, 2017 | 20.76M | 2.84M | 15.85% |
Dec 31, 2016 | 17.92M | 2.53M | 16.47% |
Dec 31, 2015 | 15.39M | 3.18M | 26.02% |
Dec 31, 2014 | 12.21M | 4.41M | 56.56% |
Dec 31, 2013 | 7.80M | 2.78M | 55.24% |
Dec 31, 2012 | 5.02M | 2.22M | 78.88% |
Dec 31, 2011 | 2.81M | 1.13M | 67.06% |
Dec 31, 2010 | 1.68M | 651.31K | 63.24% |
Dec 31, 2009 | 1.03M | -72.09K | -6.54% |
Dec 31, 2008 | 1.10M | -2.33K | -0.21% |
Dec 31, 2007 | 1.10M | -410.17K | -27.08% |
Dec 31, 2006 | 1.51M | 765.97K | 102.33% |
Dec 31, 2005 | 748.52K | 37.49K | 5.27% |
Dec 31, 2004 | 711.04K | -101.81K | -12.53% |
Dec 31, 2003 | 812.84K | 280.82K | 52.78% |
Dec 31, 2002 | 532.02K | -133.91K | -20.11% |
Dec 31, 2001 | 665.93K | -221.38K | -24.95% |
Dec 31, 2000 | 887.31K | 87.31K | 10.91% |
Dec 31, 1999 | 800.00K | 100.00K | 14.29% |
Dec 31, 1998 | 700.00K | - | - |
Dec 31, 1997 | 700.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Eli Lilly | 35.93B |
BIOYF News
- 5 weeks ago - BioSyent In-Licenses Endocrinology Product for Canada - GlobeNewsWire
- 2 months ago - BioSyent Releases Financial Results for Q1 2024 - GlobeNewsWire
- 2 months ago - BioSyent Declares Second Quarter 2024 Dividend - GlobeNewsWire
- 2 months ago - BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024 - GlobeNewsWire
- 3 months ago - BioSyent to Attend Planet MicroCap Showcase - GlobeNewsWire
- 3 months ago - BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement - GlobeNewsWire
- 3 months ago - BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 4 months ago - BioSyent to Present at LD Micro New York Investor Conference - GlobeNewsWire